What can healthcare professionals and their organisations do?
- follow us on our social media channels and show your support for the importance of reporting adverse drug reactions (ADRs) by retweeting, commenting, liking, and sharing material with your social media contacts. You can follow us via:
- encourage dialogue between your colleagues and your patients about the importance of reporting suspected ADRs. Engage locally with your regional Yellow Card Centre or your local Medication Safety Officer (MSO) in England at your hospital trust
- don’t wait to report any suspected ADRs to the Yellow Card Scheme
The reporting of suspected ADRs is key to patient safety. This campaign—the first of its kind in Europe—will help encourage greater local and national awareness about the importance of reporting to support the earlier detection of safety issues.
We also have dedicated guidance on the Yellow Card scheme for healthcare professionals. In addition to suspected adverse reactions to medicines, the Yellow Card scheme also collects reports on potential problems or incidents involving medical devices, defective medicines, counterfeits, herbal and homeopathic products, and e-cigarettes or their refill containers (e-liquids).
Article citation: Drug Safety Update volume 10 issue 4, November 2016: 2.